An HPLC Determination of Trimetazidine in Human Plasma Using Liquid‐Liquid Extraction for Sample Clean‐Up

References

• Kantor , P. F. , Lucien , A. , Kozak , R. and Lopaschuk , G. D. 2000 . The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long‐chain 3‐ketoacyl coenzyme . A thiolase. Circ. Res. , 86 : 580 – 588 .
   PubMed Web of Science ®Google Scholar
• Lionel , H. and Opie , F. B. 1995 . Trimetazidine and myocardial ischemic contracture in isolated rat heart . Am. J. Cardiol. , 76 : 38B – 40B .
   Web of Science ®Google Scholar
• Chierchia , S. L. and Fragasso , G. 1999 . Protective effects of trimetazidine on ischeaemic myocardial dysfunction . Eur. Heart J. , 1 : 24 – 27 .
   Web of Science ®Google Scholar
• Maridonneau‐Parini , I. 1986 . Effect of trimetazidine on membrane change induced by oxygen free‐radicals in human red cells . Press Med. , 15 : 1762 – 1764 .
   PubMed Web of Science ®Google Scholar
• Renaud , J. F. 1988 . Internal pH, Na, and Ca2+ regulation by trimetazidine during cardiac cell acidosis . Cardiovasc Drugs Ther. , 1 : 677 – 686 .
   PubMedGoogle Scholar
• D'hahan , N. 1999 . Trimetazidine potential mechanisms of action in hypertrophic cardiomyopathy . J. Cardiovasc. Pharmacol. , 33 : 500 – 506 .
   PubMed Web of Science ®Google Scholar
• Fragasso , G. , Piatti , P. M. , Monti , L. , Palloshi , A. , Setola , E. , Puccetti , P. , Calori , G. , Lopaschuk , D. and Margonato , A. 2003 . Short‐ and long‐term beneficial effect of trimetazidine in patients with diabetes and ischemic cardiomyopathy . Am. Heart. J. , 5 : 146
   Google Scholar
• Krishnaiah , Y. , Karthikeyan , R. S. , Gouri Sankar , V. and Satyanarayana , V. 2002 . Three‐layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride . J. Controlled Rel. , 81 : 45 – 56 .
   PubMed Web of Science ®Google Scholar
• Barre , J. , Leudal , P. , Oosterhuis , B. , Brakenhoff , J. P.G. , Wilkens , G. , Sollie , F. A.E. and Tran , D. 2003 . Pharmacokinetic profile of a modified release formulation of trimetazidine(TMZ MR 35 mg) in the elderly and patients with renal failure . Biopharm. Drug Dispos. , 24 : 159 – 164 .
   PubMed Web of Science ®Google Scholar
• Moffat , A. C. , ed. 1986 . Clarke's Isolation and Identification of Drugs in Pharmaceuticals. Body Fluids and Post Mortem Materials , Second Edition 1048 The Pharmaceutical Press .
   Google Scholar
• Fay , L. , Michel , G. , Goupit , P. , Harpey , C. and Prost , M. 1989 . Determination of trimetazidine in biological fluids by gas chromatography‐mass spectrometry . J. Chromatogr. B , 490 : 198 – 205 .
   Google Scholar
• Ghoneim , M. M. , Khashaba , P. Y. and Beltagi , A. M. 2002 . Determination of trimetazidine HCl by adsorptive stripping square‐wave voltammetry at a glassy carbon electrode . J. Pharm. Biomed. Anal. , 27 : 235 – 241 .
   PubMed Web of Science ®Google Scholar
• Leonidas , P. , Palilis , X. , Antony , C. and Calokerinos , X. 2000 . Analytical applications of chemiluminogenic reactions . Anal. Cemica Acta. , 413 : 175 – 186 .
   Web of Science ®Google Scholar
• Simmy , O. , Thoppil , X. , Rita , M. , Cardoza , P. D. and Amin , X. 2001 . Stability indicating HPTLC determination of Trimetazidine as bulk drug and in pharmacertical formulations . J. Pharm. Biomed. Anal. , 25 : 15 – 20 .
   PubMed Web of Science ®Google Scholar
• Courte , S. and Bromet , N. 1981 . Trace determination of trimetazidine in plasma by high performance liquid chromatography using fluorescence detection . J. Chromatogr. B , 224 : 162 – 167 .
   Google Scholar